(Q53675239)

17 May 2018

title

Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature. (English)

1 reference

17 May 2018

1 reference

1 reference

4

Thomas Benzing

1 reference

17 May 2018

Tuelay Kisner

1

1 reference

17 May 2018

Volker Burst

series ordinal

2

1 reference

17 May 2018

Sven Teschner

series ordinal

3

1 reference

17 May 2018

Christine E Kurschat

series ordinal

5

1 reference

17 May 2018

publication date

26 January 2012

1 reference

17 May 2018

published in

The Nephron Journals

1 reference

17 May 2018

volume

120

1 reference

17 May 2018

issue

2

1 reference

17 May 2018

page(s)

c79-85

1 reference

17 May 2018

Adult minimal-change disease: clinical characteristics, treatment, and outcomes.

cites work

1 reference

Pathogenesis and therapy of focal segmental glomerulosclerosis: an update

21 January 2018

1 reference

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations

21 January 2018

1 reference

Chronic calcineurin inhibitor nephrotoxicity-lest we forget

21 January 2018

1 reference

New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome

21 January 2018

1 reference

Rituximab for refractory focal segmental glomerulosclerosis

21 January 2018

1 reference

Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report

21 January 2018

1 reference

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

21 January 2018

1 reference

Posttransplant recurrence of primary glomerulonephritis

21 January 2018

1 reference

Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis

21 January 2018

1 reference

Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy

21 January 2018

1 reference

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial

21 January 2018

1 reference

Rituximab in refractory nephrotic syndrome.

21 January 2018

1 reference

Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis?

21 January 2018

1 reference

An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases

21 January 2018

1 reference

Rituximab for idiopathic membranous nephropathy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000335142

1 reference

17 May 2018

1 reference

17 May 2018